Newsroom
Sorted by: Latest
-
LandBridge Schedules Second Quarter Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE TX: LB) ("LandBridge") today announced that it will release its financial results for the second quarter of 2026 after market close on Wednesday, August 5, 2026. LandBridge will host a webcast and conference call to discuss its results on Thursday, August 6, 2026, at 10 a.m. Central Time / 11:00 a.m. Eastern Time. Webcast Instructions: To listen to the live webcast, please visit the Events and Presentations section of the LandBrid...
-
AGI Second Quarter 2026 Results Release Date and Conference Call
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we” or “our”) will hold a conference call on Thursday, July 30, 2026, at 8:00am ET to discuss its results for the three-months ending June 30, 2026. A news release announcing AGI’s results will be issued after markets close on Wednesday, July 29, 2026. To attend the event, please join using the AGI Second Quarter Results webcast link. Alternatively, participants can dial-in using +1-833-821-0159...
-
WaterBridge Schedules Second Quarter Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--WaterBridge Infrastructure LLC (NYSE: WBI; NYSE TX: WBI) ("WaterBridge") today announced that it will release its financial results for the second quarter of 2026 after market close on Wednesday, August 5, 2026. WaterBridge will host a webcast and conference call to discuss its results on Thursday, August 6, 2026, at 11 a.m. Central Time / 12:00 p.m. Eastern Time. Webcast Instructions: To listen to the live webcast, please visit the Events and Presentations section of...
-
Aptar Named Among Top 100 of America’s Best Companies by TIME
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named Among Top 100 of America’s Best Companies by TIME...
-
HistoSonics obtient le marquage CE qui ouvre l'accès à l'ensemble de l'Europe et accélère la commercialisation mondiale de la plateforme d'histotripsie du système Edison®
MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics a annoncé aujourd'hui avoir obtenu le marquage CE en Europe de son système Edison®, ce qui permet la commercialisation de sa technologie d'histotripsie non invasive en Europe et sur d'autres marchés reconnaissant le marquage CE. Le système Edison est une plateforme innovante, non invasive et guidée par l'image, destinée à la destruction des tumeurs hépatiques, notamment la destruction partielle ou totale des tumeurs hépatiques non résécables. Cette plat...
-
Cloudflare stellt Precursor vor: Verhaltensbasierter Schutz gegen moderne Bots mit nur einem Klick
SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), das führende Cloud-Unternehmen für Konnektivität, gab heute die allgemeine Verfügbarkeit von Precursor bekannt, einer kontinuierlichen Verhaltensvalidierungs-Engine der nächsten Generation für das Bot-Management. Precursor basiert direkt auf dem Edge-Netzwerk von Cloudflare und läuft nahtlos in Webbrowsern, um gesamte Nutzersitzungen zu überwachen und so automatisierte Bot-Aktivitäten zu erkennen. Im Gegensatz zu herkömmlichen, stati...
-
ヒストソニックス、CEマークを取得し、欧州全域で「Edison®ヒストトリプシー・プラットフォーム」の利用に道を開くとともに、世界的な商業展開を加速
ミネアポリス--(BUSINESS WIRE)--(ビジネスワイヤ) -- ヒストソニックスは、Edison®システムが欧州でCEマークを取得したと発表しました。これにより、同社は非侵襲的ヒストトリプシー技術を欧州およびCEマークが規制上認められているその他の市場で商業展開できるようになります。 Edisonシステムは、切除不能な肝腫瘍を部分的または完全に破壊することも含め、肝腫瘍の破壊を目的とした新しい非侵襲的画像誘導型プラットフォームです。同システムは、ヒストトリプシーと呼ばれる手法で集束超音波の機械的作用を利用し、侵襲的な処置や放射線照射を必要とせず、1回の処置で不要な組織や腫瘍を液化・破壊します。従来療法と比べて副作用が少ない可能性もあります。 今回のCEマーク取得は、相次ぐ規制当局の認可に続くもので、肝腫瘍治療におけるヒストトリプシーの安全性と有効性を示す臨床エビデンスの蓄積に裏付けられています。Edisonシステムを評価した臨床試験では、良好な安全性プロファイルを維持し、従来の熱凝固療法や外科的治療に伴う多くの合併症を回避しつつ、肝腫瘍を正確に標的化して破壊できることが示...
-
Stewart Information Services Corporation Announces Second Quarter 2026 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Stewart Information Services Corporation (NYSE: STC) announced today it will hold a conference call to discuss second quarter 2026 earnings at 8:30 a.m. Eastern Time on Thursday, July 23, 2026. The call will follow the company’s release of earnings after the close of trading on Wednesday, July 22. Individuals wishing to participate can dial (800) 420-1459 (USA) and (203) 518-9861 (International) – access code STCQ226. The conference call replay will be available from 1...
-
LE DEXCOM G7 15 JOURS A OBTENU L’AUTORISATION DE SANTÉ CANADA : UNE DURÉE DE PORT PROLONGÉE ET UNE CONTINUITÉ AMÉLIORÉE POUR LES ADULTES CANADIENS VIVANT AVEC LE DIABÈTE
BURNABY, Colombie-Britannique--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ : DXCM), leader mondial dans le domaine des biocapteurs de glucose, a annoncé aujourd’hui que Santé Canada a autorisé la mise en marché du système de surveillance continue du glucose (SCG) Dexcom G7 15 jours pour les personnes âgées de 18 ans et plus vivant avec le diabète. Le Dexcom G7 15 jours est le système de SCG homologué par Santé Canada offrant la plus longue durée de port et la meilleure exactitude1-4. Il fournit des v...
-
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real‑time glucose readings for an industry‑leading 15.5 days5. Building on the performance of Dexcom CGM whi...